Adult obesity is rising in the United States – with a greater impact on racial and ethnic minorities – a U.S. Centers for Disease Control (CDC) report showed, at a time when the health condition is seen causing heightened risk for severe Covid-19.
If you are not happy with the results below please do another search
50 search results for:
Pfizer vaccine trial bets on early win against coronavirus, documents show (Reuters) – Pfizer Inc PFE.N is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run. In recent weeks, […]
Global coronavirus cases exceeded 30 million, according to a Reuters tally, with the pandemic showing no signs of slowing.
New York state filed civil charges accusing Johnson & Johnson of insurance fraud for downplaying the risks of opioid painkillers, including to doctors and elderly patients.
In anticipation of data from a Phase III vaccine candidate study potentially becoming available in October, Germany’s BioNTech acquired a manufacturing facility from Novartis to boost production capabilities for the preventative treatment for the novel coronavirus.
Somerville, Massachusetts-based Finch Therapeutics closed a $90 million Series D financing, with plans to use the funds to advance the company’s lead candidate CP101 for recurrent C. difficile infection through the final stages of clinical development and regulatory submission.
One in seven cases of Covid-19 reported to the World Health Organization is a health worker and in some countries that figure rises to one in three, according to the WHO.
The U.S. National Institutes of Health launched a clinical trial of fostamatinib, currently used to treat a blood platelet-destroying autoimmune disorder, in patients hospitalized with severe Covid-19.
Eli Lilly and Co. has partnered with Amgen Inc. to increase the supply of the Indianapolis-based company’s experimental Covid-19 antibody treatments, a day after one of the drugs was shown to reduce the need for hospitalization.
Fernando Fernandez, Managing Director of FCB Health Network’s BX – Brand Experience Design Group, talked to Med Ad News about how COVID-19 has changed the way people interact with brands, how branding innovations such as audio and motion identities are making their way to pharma, and other topics.